Alon Medtech Ventures
Alon Medtech Ventures is a venture capital fund investing in Israel and Global, focused on Biotech and Healthcare. They write Pre-seed and Seed cheques. We hold 11 investments for them on record. 8 people are listed at the firm.
alon-medtech.com- Sectors
- BiotechHealthcare
- Cheque size
- Not on record
What Alon Medtech Ventures invests in
Early-stage investor backing novel medical devices that improve well-being, with hands-on guidance from concept to market.
People at Alon Medtech Ventures
8 named people on record.
- Anat Rosenthala•••••@alon-medtech.com
- Assaf Mansoura•••••@alon-medtech.com
Contact addresses at Alon Medtech Ventures are partly hidden. Create a free account to see full addresses, a fit score against your own startup, and an outreach email written for this investor.
6 more people at Alon Medtech Ventures.
The first two are open to everyone. A free account opens the rest — their names, roles and full contact addresses. No card, no demo call.
Alon Medtech Ventures portfolio
11 investments on record. Each row says whether the round came from the fund's own portfolio page or from the press, so you can check it.
| Company | Sector | Round | Amount | Date |
|---|---|---|---|---|
| RenalyDevelops therapeutic neuromodulation ultrasound technology for resistant hypertension | HealthcareIsrael | — | — | —their site |
| HealthcareIsrael | — | — | —their site |
9 more investments on record for Alon Medtech Ventures.
The first two are open to everyone. A free account opens the rest — the company, the round, the amount, the date and where each number came from. No card, no demo call.
Investors similar to Alon Medtech Ventures
DeerfieldInvests across the healthcare ecosystem, building companies and backing innovators with…
Goodwater CapitalBacks consumer and prosumer tech at every stage, using data-driven research and…
Or browse the whole directory.
Write to Alon Medtech Ventures with something they'll read.
Pitch2Fund scores your startup against Alon Medtech Ventures's actual thesis and portfolio, then writes the email — citing the companies they've already backed and why yours fits beside them. Free, and you keep the contacts.